ClinicalTrials.govpublic full text
Impact of Peptides and Chelators on Somatostatin Receptor Antagonists
neuroendocrine tumors, somatostatin receptor antagonist, pet/ct, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968782
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.